BridgeMD
New treatment option for Breast Cancer Prevention
Official title MELIORA Data Collection Campaigns
ClinicalTrials.gov ID: NCT07190066
What this study is testing
- What it's testing
- To support the development of the MELIORA digital app for the MELIORA main intervention, an initial pilot study (Data Collection Campaign, DCC) is being conducted with the three target participant groups: healthy women at increased risk of developing breast cancer (BC), BC patients, and BC survivors across the four intervention countries (Spain, Greece, Lithuania, Sweden). The planned sample size for each group is 156 healthy women at risk (defined as not meeting recommendations for a healthy lifestyle), 58 BC patients, and 86 BC survivors.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only. Healthy volunteers may be eligible.
You may be able to join if
- Individuals residing in Greece, Lithuania, Spain or Sweden.
- Female adults (i.e. ≥18 years of age).
- Ability to understand and complete the outcome measures in one of the participating countries' local languages.
- Ability to provide fully informed consent.
- Having access to and being able to use a smartphone that supports the project app (i.e., iOS or Android smartphone)
You likely can't join if
- Inability to provide fully informed consent.
- Inability to understand and communicate in one of the recruitment countries' local languages.
See the full eligibility criteria
- Individuals residing in Greece, Lithuania, Spain or Sweden.
- Female adults (i.e. ≥18 years of age).
- Ability to understand and complete the outcome measures in one of the participating countries' local languages.
- Ability to provide fully informed consent.
- Having access to and being able to use a smartphone that supports the project app (i.e., iOS or Android smartphone)
- Meeting the criteria for allocation to one of the three following groups:
- Healthy women with a calculated Βody Μass Ιndex (BMI) ≥ 25 or not meeting the World Health Organization's recommendations of ≥150 minutes of moderate-to-vigorous physical activity per week.
- Women currently undergoing active treatment for breast cancer or awaiting to begin active treatment for breast cancer.
- Women survivors of BC having completed active treatment at least six months prior to study enrolment
- Inability to provide fully informed consent.
- Inability to understand and communicate in one of the recruitment countries' local languages.
The study team makes the final eligibility decision.
Where it's taking place
- Athens, Greece
- Kaunas, Lithuania
- Valencia, Spain
- Stockholm, Sweden
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Athens, Greece; Kaunas, Lithuania; Valencia, Spain; Stockholm, Sweden. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.